When a patient has knee arthritis, in general, treatment is only supportive, until a total knee replacement is performed. Knee Replacements are delayed until a patient reaches a certain age, as we have found that knee replacements performed in younger patients have a higher rate of revision when compared with older patients. This is due to many reasons and is discussed here. Over the last 10 years, Stem Cells have become more popular for researchers who are looking for ways to regenerate cartilage. Cartilage has no blood supply and relies on its bond with the underlying bone to survive. Cartilage has no ability to repair, but the body can produce a structure similar to cartilage, which is actually scar tissue. Scar tissue can fill in small holes in the cartilage, but does not have the same properties as normal joint cartilage (Hyaline Cartilage). Therefore, it is more easily damaged.
The History of Stem Cell Research
For some time, scientists have been using stem cells to generate other parts of the body. The Vacanti Mouse is the famous mouse that had an ear grown on its back — cartilage was seeded into an ear-shaped mould and grew on its own. This is just one example of how stem cells might be used to grow certain types of cartilage. Whilst this is not necessarily the way we will see stem cells applied clinically, it illustrates the exciting possibilities in this area.
Stem cells, particularly mesenchymal stem cells (MSCs), have the potential to differentiate into cartilage-producing cells called chondrocytes. Current evidence suggests that stem cells can create cartilage, but the difficulty lies in controlling where and how the cartilage cells are deposited. The direction of growth remains difficult to control, and at this present time, stem cells do not provide a reliably safe way of alleviating the pain associated with knee arthritis.
What the Meta-Analysis Evidence Shows
A systematic review and meta-analysis examining the use of stem cells for knee osteoarthritis found no major improvement in pain or function compared to placebo (saline injection) controls. When pooled data from multiple randomised controlled trials were analysed, the effect sizes were small and clinically insignificant for the primary outcomes of pain relief and functional improvement.
This is an important finding. Much of the enthusiasm around stem cell therapy for knee arthritis has been driven by case series and small studies without control groups. When rigorous placebo-controlled trials are conducted, the advantage over simple saline injection tends to disappear — suggesting a significant placebo effect component in earlier positive reports.
"When placebo-controlled meta-analyses are applied to stem cell therapy for knee osteoarthritis, no major improvement over control is consistently demonstrated."
Systematic review finding — stem cells & knee OAThe Current Position
A recent article published on stem cells and their application in osteoarthritis suggested that successful routine clinical use is at least 5–10 years away. Significant hurdles remain — including standardising cell sources, determining optimal dosing and delivery, controlling cartilage growth direction, and demonstrating durable long-term benefit in large well-designed trials.
At the moment, we are awaiting further research before stem cell therapy becomes a proven treatment modality for knee arthritis. The technology is fascinating, and the science continues to develop rapidly. However, patients should be cautious about commercial offerings claiming established results — the evidence does not currently support routine use.
More Information
Learn more about this procedure and what to expect during your consultation.